26
total announcements
SOLARA.NS · 15 min delayed
Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.
Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange about approval of Reminder-cum-Forfeiture Notice by the Rights Issue Committee members, to be issued to the partly paid shareholders.
Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has published a newspaper advertisement regarding the dispatch of notices to shareholders for the transfer of equity shares to the Investor Education and Protection Fund (IEPF) in respect of the unclaimed and unpaid dividend for the financial year 2018-19.
Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has issued a notice to shareholders regarding the transfer of unclaimed and unpaid dividend for the financial year 2018-19 to the Investor Education and Protection Fund (IEPF) Authority. Shareholders who have not claimed the dividend amounts for a consecutive period of 7 years will have their shares transferred to the IEPF Authority on September 10, 2026, and will no longer be entitled to future benefits, including dividends.
Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in the securities of the Company shall be closed with effect from Wednesday, July 1, 2026, till 48 hours from the date of declaration of financial results of the Company for the quarter ended June 30, 2026.
Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has announced that Crisil Ratings Limited has upgraded its credit ratings for bank loan facilities totaling Rs. 791.2 Crore. The long-term rating has been upgraded to 'Crisil BBB+/Stable' from 'Crisil BBB/Stable', and the short-term rating has been upgraded to 'Crisil A2' from 'Crisil A3+'. This upgrade reflects an improvement in the company's financial risk profile and creditworthiness.